Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin’s lymphoma. Results of the HDR-ALLO study – a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Haematologica. 2012 Feb;97(2):310-7. doi: 10.3324/haematol.2011.045757.…
Use of a mouse model of pancreatic neuroendocrine tumors to find pericyte biomarkers of resistance to anti-angiogenic therapy
Horm Metab Res. 2011 Nov;43(12):884-9. doi: 10.1055/s-0031-1284381.…
Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance
Blood. 2011 Oct 27;118(17):4547-53. doi: 10.1182/blood-2011-04-345801.…
Current experience and prospect of internet consultation in fetal cardiac ultrasound
Fetal Diagn Ther. 2011;30(2):83-7. doi: 10.1159/000330113. Epub…
Collaborative study on 3-dimensional sonography for the prenatal diagnosis of central nervous system defects
J Ultrasound Med. 2011 Jul;30(7):1003-8. doi: 10.7863/jum.2011.30.7.1003.ABSTRACTOBJECTIVES:…
Non-invasive monitoring of hypoxia-inducible factor activation by optical imaging during antiangiogenic treatment in a xenograft model of ovarian carcinoma
Int J Oncol. 2011 Sep;39(3):543-52. doi: 10.3892/ijo.2011.1074.…
Fetal optic nerve sheath measurement as a non-invasive tool for assessment of increased intracranial pressure
Ultrasound Obstet Gynecol. 2011 Dec;38(6):646-51. doi: 10.1002/uog.9050.…
Glycolytic phenotype and AMP kinase modify the pathologic response of tumor xenografts to VEGF neutralization
Cancer Res. 2011 Jun 15;71(12):4214-25. doi: 10.1158/0008-5472.CAN-11-0242.…
Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation
J Clin Oncol. 2011 May 20;29(15):1980-6. doi: 10.1200/JCO.2010.30.4121.…
The adaptive stroma joining the antiangiogenic resistance front
J Clin Invest. 2011 Apr;121(4):1244-7. doi: 10.1172/JCI46430.…
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing
Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4394-9. doi: 10.1073/pnas.1014720108.…
MicroRNA control of lymphocyte differentiation and function
Curr Opin Immunol. 2011 Jun;23(3):368-73. doi: 10.1016/j.coi.2011.02.001.…
